Company Update CIPLA LTD. - 500087 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure … BSE India Company has received final approval from USFDA for NDA submitted for Nilotinib Capsules 50, 150 and 200 mg on 19th February, 2025